Free Trial
→ M.A.G.A. is Finished – This Could be even Better (From Paradigm Press) (Ad) Buy PRLB Stock  Free PRLB Stock Alerts

Proto Labs (PRLB) Financials

Proto Labs logo
$35.02 +1.21 (+3.56%)
As of 03:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Proto Labs

Annual Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 42 47 43 52 77 64 51 33 -103 17 17
Consolidated Net Income / (Loss)		 42 47 43 52 77 64 51 33 -103 17 17
Net Income / (Loss) Continuing Operations		 42 47 43 52 77 64 51 33 -103 17 17
Total Pre-Tax Income 		61 68 64 74 92 81 63 40 -98 28 25
Total Operating Income		 61 67 62 72 89 80 60 40 -98 28 20
Total Gross Profit		 128 154 167 194 239 235 218 223 215 222 223
Total Revenue		 210 264 298 344 446 459 434 488 488 504 501
Operating Revenue		 210 264 298 344 446 459 434 488 488 504 501
Total Cost of Revenue		 81 110 131 151 207 223 217 265 273 282 278
Operating Cost of Revenue		 81 110 131 151 207 223 217 265 273 282 278
Total Operating Expenses		 68 87 105 122 150 155 158 182 313 194 203
Selling, General & Admin Expense		 22 30 37 41 53 50 52 56 68 66 64
Marketing Expense		 29 39 46 57 69 73 69 82 83 88 92
Research & Development Expense		 17 18 22 24 29 33 37 44 38 40 41
Impairment Charge		 - - - - - - 0.00 0.00 118 0.00 0.00
Restructuring Charge		 - - - - - - - - 6.92 0.22 5.59
Total Other Income / (Expense), net		 0.00 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76
Other Income / (Expense), net		 0.00 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76
Income Tax Expense		 19 21 22 23 15 18 12 6.81 5.59 11 8.08
Basic Earnings per Share		 $1.62 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66
Weighted Average Basic Shares Outstanding		 25.69M 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M
Diluted Earnings per Share		 $1.60 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66
Weighted Average Diluted Shares Outstanding		 26.10M 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M
Weighted Average Basic & Diluted Shares Outstanding		 25.70M 26M 26.40M 26.70M 27M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M

Quarterly Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 3.95 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40
Consolidated Net Income / (Loss)		 3.95 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40
Net Income / (Loss) Continuing Operations		 3.95 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40
Total Pre-Tax Income 		6.03 -117 5.04 2.24 11 9.94 7.73 7.36 9.87 -0.28
Total Operating Income		 6.06 -117 3.75 5.61 10 8.40 6.83 6.00 8.58 -1.50
Total Gross Profit		 54 49 54 53 59 56 57 57 57 52
Total Revenue		 122 116 126 122 131 125 128 126 126 122
Operating Revenue		 122 116 126 122 131 125 128 126 126 122
Total Cost of Revenue		 68 67 72 69 71 69 70 69 68 70
Operating Cost of Revenue		 68 67 72 69 71 69 70 69 68 70
Total Operating Expenses		 48 166 50 48 49 47 51 51 49 53
Selling, General & Admin Expense		 16 18 17 16 17 16 16 17 16 15
Marketing Expense		 21 21 22 22 22 22 23 23 23 23
Research & Development Expense		 9.31 8.91 11 9.87 10 9.49 11 11 9.77 9.70
Total Other Income / (Expense), net		 -0.02 0.43 1.29 -3.37 0.32 1.54 0.90 1.36 1.29 1.21
Other Income / (Expense), net		 -0.02 0.43 1.29 -3.37 0.32 1.54 0.90 1.36 1.29 1.21
Income Tax Expense		 2.08 -1.64 2.38 2.62 2.78 2.95 2.46 2.82 2.68 0.12
Basic Earnings per Share		 $0.14 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02)
Weighted Average Basic Shares Outstanding		 27.51M 27.41M 26.58M 26.21M 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M
Diluted Earnings per Share		 $0.14 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01)
Weighted Average Diluted Shares Outstanding		 27.51M 27.41M 26.61M 26.21M 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M
Weighted Average Basic & Diluted Shares Outstanding		 27.12M 26.68M 26.20M 26.10M 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M

Annual Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 0.29 4.32 21 -32 48 40 2.38 -62 -9.37 27 5.28
Net Cash From Operating Activities		 57 64 77 82 123 116 107 55 62 73 78
Net Cash From Continuing Operating Activities		 57 64 77 82 123 116 107 55 62 73 78
Net Income / (Loss) Continuing Operations		 42 47 43 52 77 64 51 33 -103 17 17
Consolidated Net Income / (Loss)		 42 47 43 52 77 64 51 33 -103 17 17
Depreciation Expense		 11 14 17 18 27 31 33 40 39 38 36
Non-Cash Adjustments To Reconcile Net Income		 0.34 5.74 5.69 8.92 9.64 11 15 19 137 20 20
Changes in Operating Assets and Liabilities, net		 2.58 -3.52 10 1.52 9.58 10 8.76 -38 -11 -1.93 5.82
Net Cash From Investing Activities		 -63 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14
Net Cash From Continuing Investing Activities		 -63 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14
Purchase of Property, Plant & Equipment		 -44 -44 -34 -33 -87 -62 -47 -34 -22 -28 -9.17
Purchase of Investments		 -60 -66 -89 -29 -42 -50 -116 -16 -47 -1.00 -25
Sale of Property, Plant & Equipment		 - - - - - - 0.00 0.00 4.11 0.70 0.03
Sale and/or Maturity of Investments		 74 52 62 48 65 68 68 83 21 24 21
Net Cash From Financing Activities		 7.04 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59
Net Cash From Continuing Financing Activities		 7.04 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59
Repayment of Debt		 -1.05 -0.15 0.00 0.00 -5.00 0.00 -0.15 -0.56 -0.53 -0.31 -0.30
Repurchase of Common Equity		 - 0.00 0.00 -4.41 -12 -34 -15 -23 -30 -44 -60
Issuance of Common Equity		 4.82 6.25 5.72 8.60 8.94 4.39 7.56 5.86 3.95 3.84 4.02
Other Financing Activities, net		 4.47 - - 0.00 -2.14 -2.49 -3.44 -4.23 -1.68 -1.44 -2.00
Effect of Exchange Rate Changes		 -0.46 -0.88 -0.92 0.95 - 0.05 - -0.05 -0.44 0.37 -0.42
Cash Interest Paid		 0.02 0.01 0.00 0.02 0.04 0.01 0.02 0.03 0.10 1.06 0.14
Cash Income Taxes Paid		 12 20 9.80 19 9.97 4.00 5.65 7.58 19 16 14

Quarterly Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 4.70 -2.80 5.49 4.44 17 0.29 9.01 3.35 -8.28 1.20
Net Cash From Operating Activities		 21 11 23 9.29 24 17 21 14 25 17
Net Cash From Continuing Operating Activities		 21 11 23 9.29 24 17 21 14 25 17
Net Income / (Loss) Continuing Operations		 3.95 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40
Consolidated Net Income / (Loss)		 3.95 -115 2.66 -0.38 7.95 6.99 5.27 4.54 7.19 -0.40
Depreciation Expense		 9.71 9.44 9.39 9.50 9.33 9.32 9.10 8.97 8.91 8.82
Non-Cash Adjustments To Reconcile Net Income		 4.78 122 3.98 7.43 4.66 4.37 4.26 4.25 4.46 6.63
Changes in Operating Assets and Liabilities, net		 2.08 -6.05 6.55 -7.26 2.23 -3.45 2.70 -3.32 4.20 2.24
Net Cash From Investing Activities		 -6.85 0.27 4.38 3.43 2.06 -14 4.42 -0.75 -14 -2.90
Net Cash From Continuing Investing Activities		 -6.85 0.27 4.38 3.43 2.06 -14 4.42 -0.75 -14 -2.90
Purchase of Property, Plant & Equipment		 -10 -5.27 -3.44 -3.39 -3.11 -18 -2.59 -4.20 -1.56 -0.83
Purchase of Investments		 -6.99 -1.00 - - - -1.00 - - - -6.98
Sale and/or Maturity of Investments		 7.30 5.66 7.63 6.39 5.10 4.75 6.98 3.44 5.29 4.92
Net Cash From Financing Activities		 -7.97 -15 -22 -8.06 -9.07 -3.12 -17 -10 -19 -13
Net Cash From Continuing Financing Activities		 -7.97 -15 -22 -8.06 -9.07 -3.12 -17 -10 -19 -13
Repayment of Debt		 -0.14 -0.11 -0.08 -0.08 -0.07 -0.07 -0.07 -0.07 -0.07 -0.08
Repurchase of Common Equity		 -7.84 -17 -21 -8.95 -8.99 -4.90 -16 -11 -19 -14
Other Financing Activities, net		 - -0.07 -0.40 0.96 -0.01 -1.99 -0.53 0.71 - -2.17
Effect of Exchange Rate Changes		 -1.01 1.54 0.13 -0.21 -0.16 0.61 -0.12 -0.05 0.41 -0.65

Annual Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 287 361 414 519 619 674 744 929 802 772 744
Total Current Assets		 108 138 158 165 215 236 242 183 187 201 195
Cash & Equivalents		 43 48 69 37 85 125 128 66 57 84 89
Short-Term Investments		 31 33 39 57 47 35 34 12 24 19 14
Accounts Receivable		 24 36 34 52 59 57 58 80 76 73 67
Inventories, net		 6.19 9.77 9.31 11 10 10 11 13 14 14 12
Prepaid Expenses		 3.41 5.22 5.70 6.27 8.57 8.23 11 11 13 9.12 10
Current Deferred & Refundable Income Taxes		 0.00 6.03 0.45 1.83 5.76 0.00 0.54 1.32 4.04 2.23 2.91
Plant, Property, & Equipment, net		 92 125 139 166 228 264 283 280 258 254 227
Total Noncurrent Assets		 88 98 117 187 176 174 220 465 358 318 321
Long-Term Investments		 54 65 84 37 24 13 59 14 26 8.02 18
Noncurrent Note & Lease Receivables		 - - - - 0.00 0.00 2.40 1.90 18 0.96 0.69
Goodwill		 29 29 29 129 129 129 129 401 274 274 274
Intangible Assets		 4.08 3.34 2.66 19 20 17 14 38 31 26 21
Other Noncurrent Operating Assets		 0.23 0.52 0.93 2.67 3.44 14 15 9.90 8.62 9.48 7.52
Total Liabilities & Shareholders' Equity		 287 361 414 519 619 674 744 929 802 772 744
Total Liabilities		 21 33 34 58 77 88 100 100 105 77 73
Total Current Liabilities		 19 26 23 44 53 48 50 55 72 50 53
Accounts Payable		 7.88 14 11 16 17 17 18 25 17 16 16
Accrued Expenses		 2.72 2.63 4.44 8.41 17 11 16 12 22 17 20
Current Employee Benefit Liabilities		 6.07 9.99 7.67 12 18 15 12 14 13 15 17
Other Current Liabilities		 - - - - 0.00 3.34 3.82 3.85 19 1.88 1.60
Total Noncurrent Liabilities		 2.73 7.13 11 14 25 40 50 45 33 27 20
Noncurrent Deferred & Payable Income Tax Liabilities		 1.36 4.24 7.00 6.97 20 26 34 36 26 19 14
Other Noncurrent Operating Liabilities		 1.36 2.89 3.98 4.62 4.59 14 16 9.30 6.62 8.64 6.53
Total Equity & Noncontrolling Interests		 266 328 380 461 541 586 644 828 698 695 670
Total Preferred & Common Equity		 266 328 380 461 541 586 644 828 698 695 670
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 266 328 380 461 541 586 644 828 698 695 670
Common Stock		 181 199 214 242 259 268 285 469 474 467 454
Retained Earnings		 87 134 177 225 291 325 363 377 258 256 244
Accumulated Other Comprehensive Income / (Loss)		 -2.93 -5.21 -11 -5.23 -8.49 -7.02 -3.42 -17 -34 -28 -28

Quarterly Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 907 791 777 784 770 758 754
Total Current Assets		 192 189 185 205 210 208 193
Cash & Equivalents		 59 62 66 83 93 96 88
Short-Term Investments		 25 23 20 19 17 17 13
Accounts Receivable		 81 78 75 78 78 71 69
Inventories, net		 15 14 14 14 13 12 12
Prepaid Expenses		 12 11 8.50 8.72 9.43 10 10
Current Deferred & Refundable Income Taxes		 0.76 0.82 0.87 0.89 0.64 1.40 0.67
Plant, Property, & Equipment, net		 260 254 249 243 248 244 238
Total Noncurrent Assets		 455 349 343 337 312 307 323
Long-Term Investments		 29 20 16 12 3.26 0.00 17
Noncurrent Note & Lease Receivables		 1.52 17 17 17 0.89 0.83 0.76
Goodwill		 384 274 274 274 274 274 274
Intangible Assets		 32 30 28 27 24 23 23
Other Noncurrent Operating Assets		 8.48 8.09 7.82 7.08 9.04 8.63 8.01
Total Liabilities & Shareholders' Equity		 907 791 777 784 770 758 754
Total Liabilities		 96 108 95 99 82 73 74
Total Current Liabilities		 61 78 66 75 58 51 54
Accounts Payable		 17 20 16 18 15 16 15
Accrued Expenses		 25 23 19 21 21 18 18
Current Deferred & Payable Income Tax Liabilities		 0.01 1.93 0.35 1.14 3.88 - 0.99
Current Employee Benefit Liabilities		 15 15 12 16 16 16 18
Other Current Liabilities		 3.26 19 18 18 1.85 1.84 1.76
Total Noncurrent Liabilities		 35 30 28 25 24 22 20
Noncurrent Deferred & Payable Income Tax Liabilities		 27 23 21 17 16 15 13
Other Noncurrent Operating Liabilities		 8.51 6.60 7.51 7.56 7.58 7.44 7.35
Total Equity & Noncontrolling Interests		 811 683 683 685 687 685 680
Total Preferred & Common Equity		 811 683 683 685 687 685 680
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 811 683 683 685 687 685 680
Common Stock		 477 465 465 464 463 461 454
Retained Earnings		 381 251 247 251 253 253 253
Accumulated Other Comprehensive Income / (Loss)		 -47 -33 -29 -30 -29 -29 -27

Annual Metrics and Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 28.49% 26.02% 12.85% 15.58% 29.35% 2.95% -5.30% 12.36% 0.06% 3.17% -0.59%
EBITDA Growth		 20.74% 13.71% -0.41% 13.38% 26.40% -5.66% -14.74% -15.56% -172.46% 212.02% -7.64%
EBIT Growth		 17.36% 12.11% -5.36% 15.90% 23.13% -11.41% -22.47% -36.16% -343.57% 128.56% -11.73%
NOPAT Growth		 18.66% 10.55% -10.76% 22.32% 47.85% -15.72% -22.76% -30.71% -304.72% 125.30% -22.83%
Net Income Growth		 18.02% 11.72% -8.18% 21.24% 47.92% -16.89% -20.09% -34.39% -410.03% 116.64% -3.64%
EPS Growth		 17.65% 10.63% -9.04% 19.88% 45.60% -16.37% -19.57% -35.98% -411.57% 117.51% 0.00%
Operating Cash Flow Growth		 18.10% 12.04% 20.91% 5.48% 50.38% -5.59% -7.83% -48.36% 12.38% 18.03% 6.22%
Free Cash Flow Firm Growth		 -208.61% 105.02% 2,548.70% -371.50% 123.75% 57.51% 1.79% -851.94% 127.50% -68.83% 102.55%
Invested Capital Growth		 100.18% 32.52% 2.79% 79.09% 15.24% 6.75% 2.70% 74.02% -19.76% -1.12% -6.02%
Revenue Q/Q Growth		 6.09% 7.18% -0.47% 6.76% 4.35% -0.19% -1.51% 3.91% -1.61% 1.91% -0.65%
EBITDA Q/Q Growth		 2.73% 3.38% -1.52% 4.99% 3.90% -1.11% -7.28% 3.78% -181.19% 207.29% -15.05%
EBIT Q/Q Growth		 1.14% 3.80% -3.35% 6.07% 2.61% -2.64% -11.00% 3.56% -408.20% 128.32% -29.29%
NOPAT Q/Q Growth		 1.86% 3.13% -5.17% 10.14% 5.95% -4.24% -11.47% 9.40% -387.71% 125.46% -34.64%
Net Income Q/Q Growth		 1.68% 4.03% -5.78% 10.45% 7.01% -6.05% -9.93% 7.51% -540.02% 116.43% -30.83%
EPS Q/Q Growth		 1.27% 4.12% -5.85% 9.66% 6.84% -6.00% -10.00% 8.04% -538.37% 117.41% -29.03%
Operating Cash Flow Q/Q Growth		 6.84% 9.58% -4.27% 4.33% 14.13% -4.68% -6.70% -2.78% -16.76% 10.09% 0.08%
Free Cash Flow Firm Q/Q Growth		 7.20% -91.51% 191.18% -351.91% 121.96% 7.22% -3.39% 2.63% 9.79% -59.22% 72.65%
Invested Capital Q/Q Growth		 1.28% 10.82% -4.15% 65.86% 2.20% 0.75% -0.45% -0.89% -15.19% 2.54% -2.32%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 61.27% 58.46% 56.01% 56.27% 53.56% 51.29% 50.14% 45.62% 44.12% 44.06% 44.56%
EBITDA Margin		 34.92% 31.51% 27.81% 27.28% 26.66% 24.43% 21.99% 16.53% -11.97% 13.00% 12.07%
Operating Margin		 28.88% 25.43% 20.72% 20.97% 19.95% 17.41% 13.77% 8.27% -20.06% 5.59% 3.98%
EBIT Margin		 28.88% 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93%
Profit (Net Income) Margin		 19.87% 17.61% 14.33% 15.03% 17.19% 13.88% 11.71% 6.84% -21.18% 3.42% 3.31%
Tax Burden Percent		 68.78% 68.54% 66.50% 69.56% 83.56% 78.40% 80.81% 83.05% 105.71% 61.61% 67.25%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 31.22% 31.46% 33.50% 30.44% 16.44% 21.60% 19.19% 16.95% 0.00% 38.39% 32.75%
Return on Invested Capital (ROIC)		 40.43% 28.83% 22.26% 19.24% 20.60% 15.69% 11.58% 5.78% -10.33% 2.95% 2.36%
ROIC Less NNEP Spread (ROIC-NNEP)		 40.43% 28.47% 21.29% 18.28% 18.96% 15.05% 10.30% 5.86% 24.82% 3.07% -0.40%
Return on Net Nonoperating Assets (RNNOA)		 -22.98% -13.14% -10.18% -6.93% -5.32% -4.39% -3.31% -1.25% -3.23% -0.48% 0.07%
Return on Equity (ROE)		 17.45% 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43%
Cash Return on Invested Capital (CROIC)		 -26.32% 0.85% 19.51% -37.43% 6.44% 9.16% 8.91% -48.25% 11.59% 4.08% 8.57%
Operating Return on Assets (OROA)		 23.41% 20.94% 16.57% 15.96% 16.11% 12.56% 8.88% 4.80% -11.31% 3.55% 3.26%
Return on Assets (ROA)		 16.10% 14.35% 11.02% 11.10% 13.46% 9.85% 7.18% 3.99% -11.96% 2.19% 2.19%
Return on Common Equity (ROCE)		 17.45% 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43%
Return on Equity Simple (ROE_SIMPLE)		 15.68% 14.20% 11.24% 11.23% 14.14% 10.87% 7.89% 4.03% -14.83% 2.48% 2.48%
Net Operating Profit after Tax (NOPAT)		 42 46 41 50 74 63 48 34 -69 17 13
NOPAT Margin		 19.86% 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% -14.04% 3.44% 2.67%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.36% 0.96% 0.96% 1.64% 0.64% 1.27% -0.08% -35.16% -0.12% 2.76%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -9.83% 2.50% 2.00%
Cost of Revenue to Revenue		 38.74% 41.54% 43.99% 43.73% 46.44% 48.71% 49.86% 54.38% 55.88% 55.94% 55.44%
SG&A Expenses to Revenue		 10.56% 11.25% 12.30% 11.96% 11.78% 10.85% 11.91% 11.46% 13.83% 13.06% 12.84%
R&D to Revenue		 7.92% 6.95% 7.51% 6.84% 6.45% 7.13% 8.50% 9.06% 7.83% 7.97% 8.24%
Operating Expenses to Revenue		 32.38% 33.04% 35.29% 35.30% 33.61% 33.88% 36.37% 37.36% 64.18% 38.47% 40.59%
Earnings before Interest and Taxes (EBIT)		 61 68 64 74 92 81 63 40 -98 28 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 73 83 83 94 119 112 96 81 -58 65 60
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 5.09 3.57 5.95 5.64 4.64 6.37 1.71 0.99 1.44 1.43
Price to Tangible Book Value (P/TBV)		 0.00 5.64 3.90 8.75 7.77 6.18 8.19 3.63 1.76 2.54 2.56
Price to Revenue (P/Rev)		 0.00 6.31 4.55 7.97 6.85 5.92 9.45 2.90 1.42 1.99 1.91
Price to Earnings (P/E)		 0.00 35.82 31.78 53.01 39.87 42.69 80.68 42.45 0.00 58.34 57.74
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 2.79% 3.15% 1.89% 2.51% 2.34% 1.24% 2.36% 0.00% 1.71% 1.73%
Enterprise Value to Invested Capital (EV/IC)		 0.00 8.36 6.22 7.81 7.51 6.17 9.17 1.80 0.99 1.53 1.52
Enterprise Value to Revenue (EV/Rev)		 0.00 5.76 3.91 7.60 6.50 5.55 8.94 2.71 1.20 1.77 1.67
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 18.27 14.05 27.86 24.40 22.70 40.64 16.42 0.00 13.65 13.84
Enterprise Value to EBIT (EV/EBIT)		 0.00 22.41 18.13 35.18 31.62 31.33 61.69 32.97 0.00 31.98 33.93
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 33.04 28.35 52.12 39.01 40.63 80.30 39.54 0.00 51.51 62.52
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 23.73 15.03 32.03 23.57 21.92 36.30 23.98 9.44 12.20 10.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 1,119.01 32.35 0.00 124.84 69.58 104.34 0.00 7.61 37.27 17.24
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.57 -0.46 -0.48 -0.38 -0.28 -0.29 -0.32 -0.21 -0.13 -0.16 -0.17
Leverage Ratio		 1.08 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11
Compound Leverage Factor		 1.08 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11
Debt to Total Capital		 0.06% 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.05% 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.94% 100.00% 100.00% 98.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -1.75 0.00 0.00 -1.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -3.08 0.00 0.00 -2.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 32.19 25.89 30.65 25.82 20.64 26.52 9.90 4.80 9.29 9.31
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.75 5.25 6.74 3.77 4.08 4.97 4.82 3.34 2.61 4.04 3.66
Quick Ratio		 5.24 4.45 6.08 3.33 3.62 4.58 4.37 2.87 2.18 3.54 3.18
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -27 1.36 36 -98 23 37 37 -280 77 24 49
Operating Cash Flow to CapEx		 131.50% 144.48% 230.54% 250.49% 141.13% 186.49% 227.55% 161.48% 353.16% 267.26% 851.99%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.81 0.82 0.77 0.74 0.78 0.71 0.61 0.58 0.56 0.64 0.66
Accounts Receivable Turnover		 9.85 8.75 8.49 8.05 8.05 7.87 7.53 7.08 6.25 6.76 7.19
Inventory Turnover		 14.29 13.74 13.74 14.64 19.38 22.16 20.69 22.10 20.41 20.70 21.39
Fixed Asset Turnover		 2.84 2.43 2.25 2.25 2.26 1.87 1.59 1.73 1.82 1.97 2.08
Accounts Payable Turnover		 11.32 10.19 10.50 11.08 12.43 13.06 12.36 12.17 12.78 17.09 17.83
Days Sales Outstanding (DSO)		 37.05 41.70 42.97 45.33 45.32 46.39 48.45 51.57 58.40 53.99 50.77
Days Inventory Outstanding (DIO)		 25.54 26.56 26.56 24.93 18.84 16.47 17.64 16.52 17.88 17.63 17.06
Days Payable Outstanding (DPO)		 32.23 35.81 34.75 32.95 29.36 27.95 29.54 29.99 28.57 21.36 20.47
Cash Conversion Cycle (CCC)		 30.36 32.45 34.78 37.31 34.80 34.91 36.56 38.10 47.71 50.27 47.37
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 137 182 187 335 386 412 423 737 591 584 549
Invested Capital Turnover		 2.04 1.65 1.62 1.32 1.24 1.15 1.04 0.84 0.74 0.86 0.88
Increase / (Decrease) in Invested Capital		 69 45 5.08 148 51 26 11 313 -146 -6.63 -35
Enterprise Value (EV)		 0.00 1,521 1,165 2,618 2,898 2,544 3,883 1,325 586 894 837
Market Capitalization		 0.00 1,666 1,357 2,745 3,053 2,717 4,104 1,417 692 1,005 958
Book Value per Share		 $10.34 $12.52 $14.37 $17.31 $20.00 $21.89 $24.08 $30.03 $25.73 $26.96 $27.34
Tangible Book Value per Share		 $9.05 $11.29 $13.18 $11.77 $14.51 $16.43 $18.74 $14.13 $14.47 $15.35 $15.29
Total Capital		 266 328 380 466 541 586 644 828 698 695 670
Total Debt		 0.15 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -128 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121
Capital Expenditures (CapEx)		 44 44 34 33 87 62 47 34 18 27 9.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 15 31 26 32 31 28 30 51 35 48 38
Debt-free Net Working Capital (DFNWC)		 89 112 134 126 163 189 192 129 115 151 142
Net Working Capital (NWC)		 89 112 134 121 163 189 192 129 115 151 142
Net Nonoperating Expense (NNE)		 -0.00 -0.49 -1.63 -1.54 -2.30 -1.05 -2.51 0.13 35 0.13 -3.20
Net Nonoperating Obligations (NNO)		 -128 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121
Total Depreciation and Amortization (D&A)		 13 15 19 20 27 31 33 40 39 38 36
Debt-free, Cash-free Net Working Capital to Revenue		 7.26% 11.69% 8.75% 9.32% 6.92% 6.14% 6.92% 10.47% 7.14% 9.56% 7.68%
Debt-free Net Working Capital to Revenue		 42.58% 42.31% 45.08% 36.65% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27%
Net Working Capital to Revenue		 42.51% 42.31% 45.08% 35.20% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.62 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66
Adjusted Weighted Average Basic Shares Outstanding		 25.69M 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M
Adjusted Diluted Earnings per Share		 $1.60 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66
Adjusted Weighted Average Diluted Shares Outstanding		 26.10M 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.87M 26.20M 26.53M 26.90M 26.98M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M
Normalized Net Operating Profit after Tax (NOPAT)		 42 46 41 50 74 63 48 34 19 17 17
Normalized NOPAT Margin		 19.86% 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% 3.86% 3.47% 3.42%
Pre Tax Income Margin		 28.88% 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 2.88% 3.01% 0.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 2.88% 3.01% 0.94% 8.52% 15.97% 52.66% 28.87% 69.76% -28.67% 255.23% 363.27%

Quarterly Metrics and Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -2.89% -6.45% 1.36% -3.65% 7.38% 8.17% 1.61% 2.75% -3.89% -2.64%
EBITDA Growth		 -9.22% -562.54% -19.05% -23.02% 27.47% 117.95% 16.65% 39.17% -6.42% -55.63%
EBIT Growth		 -14.57% -1,002.44% -33.61% -56.94% 77.91% 108.52% 53.32% 228.57% -8.08% -102.84%
NOPAT Growth		 -16.35% -782.21% -62.65% -137.51% 94.54% 107.20% 135.31% 485.92% -19.00% -117.72%
Net Income Growth		 -18.28% -1,066.12% -47.81% -114.98% 101.32% 106.07% 98.12% 1,285.38% -9.62% -105.78%
EPS Growth		 -17.65% -1,052.27% -47.37% -111.11% 121.43% 106.21% 100.00% 1,900.00% -6.45% -103.85%
Operating Cash Flow Growth		 78.53% -54.32% 26.96% -29.93% 17.81% 63.84% -5.49% 55.49% 2.38% 0.38%
Free Cash Flow Firm Growth		 116.03% 121.09% 2,322.14% 241.97% 168.20% -80.28% -94.14% -91.28% -89.68% 172.35%
Invested Capital Growth		 -6.22% -19.76% -20.19% -18.39% -18.22% -1.12% -0.70% -1.31% -1.34% -6.02%
Revenue Q/Q Growth		 -4.08% -5.02% 8.87% -2.86% 6.90% -4.33% 2.27% -1.77% -0.01% -3.08%
EBITDA Q/Q Growth		 3.26% -781.40% 113.45% -18.66% 70.98% -4.05% -12.59% -2.95% 14.97% -54.51%
EBIT Q/Q Growth		 15.99% -2,034.09% 104.32% -55.55% 379.24% -7.42% -22.26% -4.74% 34.08% -102.86%
NOPAT Q/Q Growth		 55.16% -2,167.01% 102.41% -148.47% 904.79% -23.48% -21.16% -20.51% 68.92% -116.74%
Net Income Q/Q Growth		 54.52% -3,012.30% 102.31% -114.40% 2,176.76% -12.12% -24.64% -13.82% 58.35% -105.62%
EPS Q/Q Growth		 55.56% -3,092.86% 102.39% -110.00% 3,200.00% -16.13% -23.08% -10.00% 61.11% -103.45%
Operating Cash Flow Q/Q Growth		 54.82% -48.77% 114.72% -58.86% 160.30% -28.75% 23.86% -32.31% 71.39% -30.14%
Free Cash Flow Firm Q/Q Growth		 32.38% 26.55% 133.31% -12.51% 3.82% -90.69% -30.66% 30.10% 22.91% 145.62%
Invested Capital Q/Q Growth		 -1.92% -15.19% -2.15% 0.26% -1.71% 2.54% -1.73% -0.36% -1.74% -2.32%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 44.06% 42.05% 42.73% 43.45% 45.36% 44.63% 44.93% 45.01% 45.56% 42.68%
EBITDA Margin		 12.93% -92.78% 11.46% 9.60% 15.35% 15.40% 13.16% 13.00% 14.95% 7.02%
Operating Margin		 4.98% -101.32% 2.98% 4.59% 7.97% 6.71% 5.34% 4.78% 6.83% -1.23%
EBIT Margin		 4.96% -100.95% 4.00% 1.83% 8.21% 7.95% 6.04% 5.86% 7.86% -0.23%
Profit (Net Income) Margin		 3.25% -99.53% 2.11% -0.31% 6.09% 5.59% 4.12% 3.61% 5.72% -0.33%
Tax Burden Percent		 65.48% 98.60% 52.77% -17.10% 74.09% 70.34% 68.19% 61.68% 72.85% 143.26%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 34.52% 0.00% 47.23% 117.10% 25.91% 29.66% 31.81% 38.32% 27.15% 0.00%
Return on Invested Capital (ROIC)		 2.25% -52.18% 1.18% -0.59% 4.61% 4.05% 3.19% 2.60% 4.43% -0.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.26% -18.84% 0.54% -1.13% 4.40% 3.05% 2.63% 1.83% 3.62% -1.31%
Return on Net Nonoperating Assets (RNNOA)		 -0.27% 2.45% -0.08% 0.16% -0.67% -0.48% -0.42% -0.29% -0.62% 0.22%
Return on Equity (ROE)		 1.98% -49.73% 1.11% -0.43% 3.94% 3.57% 2.78% 2.32% 3.81% -0.54%
Cash Return on Invested Capital (CROIC)		 9.73% 11.59% 11.48% 9.22% 9.28% 4.08% 4.21% 5.12% 4.97% 8.57%
Operating Return on Assets (OROA)		 2.68% -56.97% 2.27% 1.05% 4.80% 5.09% 3.92% 3.89% 5.15% -0.15%
Return on Assets (ROA)		 1.75% -56.17% 1.20% -0.18% 3.56% 3.58% 2.67% 2.40% 3.75% -0.22%
Return on Common Equity (ROCE)		 1.98% -49.73% 1.11% -0.43% 3.94% 3.57% 2.78% 2.32% 3.81% -0.54%
Return on Equity Simple (ROE_SIMPLE)		 2.90% 0.00% -15.50% -15.94% -15.31% 0.00% 2.89% 3.61% 3.53% 0.00%
Net Operating Profit after Tax (NOPAT)		 3.97 -82 1.98 -0.96 7.72 5.90 4.66 3.70 6.25 -1.05
NOPAT Margin		 3.26% -70.92% 1.57% -0.78% 5.90% 4.72% 3.64% 2.95% 4.98% -0.86%
Net Nonoperating Expense Percent (NNEP)		 -0.02% -33.34% 0.64% 0.54% 0.21% 1.00% 0.56% 0.78% 0.81% 0.55%
Return On Investment Capital (ROIC_SIMPLE)		 - -11.75% - - - 0.85% - - - -0.16%
Cost of Revenue to Revenue		 55.94% 57.96% 57.27% 56.55% 54.64% 55.37% 55.07% 54.99% 54.44% 57.32%
SG&A Expenses to Revenue		 13.54% 15.37% 13.37% 12.94% 13.05% 12.86% 12.76% 13.21% 12.94% 12.46%
R&D to Revenue		 7.65% 7.70% 8.48% 8.07% 7.73% 7.59% 8.73% 8.49% 7.78% 7.97%
Operating Expenses to Revenue		 39.08% 143.36% 39.75% 38.86% 37.39% 37.92% 39.60% 40.23% 38.73% 43.90%
Earnings before Interest and Taxes (EBIT)		 6.03 -117 5.04 2.24 11 9.94 7.73 7.36 9.87 -0.28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 16 -107 14 12 20 19 17 16 19 8.54
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.24 0.99 1.29 1.34 1.01 1.44 1.34 1.14 1.09 1.43
Price to Tangible Book Value (P/TBV)		 2.53 1.76 2.33 2.41 1.79 2.54 2.37 2.02 1.93 2.56
Price to Revenue (P/Rev)		 2.02 1.42 1.80 1.89 1.39 1.99 1.82 1.54 1.46 1.91
Price to Earnings (P/E)		 42.61 0.00 0.00 0.00 0.00 58.34 46.49 31.59 30.79 57.74
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.35% 0.00% 0.00% 0.00% 0.00% 1.71% 2.15% 3.17% 3.25% 1.73%
Enterprise Value to Invested Capital (EV/IC)		 1.27 0.99 1.35 1.40 1.01 1.53 1.41 1.17 1.10 1.52
Enterprise Value to Revenue (EV/Rev)		 1.79 1.20 1.59 1.68 1.16 1.77 1.60 1.31 1.23 1.67
Enterprise Value to EBITDA (EV/EBITDA)		 12.33 0.00 0.00 0.00 0.00 13.65 11.92 9.23 8.72 13.84
Enterprise Value to EBIT (EV/EBIT)		 27.96 0.00 0.00 0.00 0.00 31.98 26.40 18.71 17.80 33.93
Enterprise Value to NOPAT (EV/NOPAT)		 37.25 0.00 0.00 0.00 0.00 51.51 40.00 30.55 30.31 62.52
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.91 9.44 11.66 12.93 8.62 12.20 11.23 8.67 7.99 10.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.67 7.61 10.42 13.67 9.76 37.27 33.35 22.68 22.07 17.24
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.12 -0.13 -0.14 -0.14 -0.15 -0.16 -0.16 -0.16 -0.17 -0.17
Leverage Ratio		 1.12 1.13 1.14 1.13 1.13 1.13 1.14 1.12 1.13 1.11
Compound Leverage Factor		 1.12 1.13 1.14 1.13 1.13 1.13 1.14 1.12 1.13 1.11
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.59 4.73 6.16 7.08 5.48 9.22 8.09 7.85 7.41 9.20
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 3.17 2.61 2.41 2.80 2.74 4.04 3.60 4.08 3.59 3.66
Quick Ratio		 2.72 2.18 2.07 2.44 2.43 3.54 3.21 3.61 3.16 3.18
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 50 64 148 130 135 13 8.69 11 14 34
Operating Cash Flow to CapEx		 286.77% 239.47% 695.35% 313.92% 796.41% 94.79% 831.89% 344.78% 1,596.00% 2,083.61%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.54 0.56 0.57 0.57 0.58 0.64 0.65 0.66 0.66 0.66
Accounts Receivable Turnover		 5.97 6.25 5.99 6.16 6.22 6.76 6.51 6.98 6.82 7.19
Inventory Turnover		 22.44 20.41 19.41 18.82 19.68 20.70 20.68 21.01 21.14 21.39
Fixed Asset Turnover		 1.83 1.82 1.87 1.91 1.97 1.97 2.02 2.07 2.10 2.08
Accounts Payable Turnover		 13.83 12.78 14.81 17.21 16.06 17.09 15.96 17.30 16.83 17.83
Days Sales Outstanding (DSO)		 61.12 58.40 60.91 59.21 58.69 53.99 56.08 52.29 53.52 50.77
Days Inventory Outstanding (DIO)		 16.27 17.88 18.80 19.39 18.55 17.63 17.65 17.37 17.27 17.06
Days Payable Outstanding (DPO)		 26.38 28.57 24.65 21.21 22.72 21.36 22.87 21.09 21.68 20.47
Cash Conversion Cycle (CCC)		 51.00 47.71 55.07 57.39 54.52 50.27 50.86 48.57 49.10 47.37
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 697 591 578 580 570 584 574 572 562 549
Invested Capital Turnover		 0.69 0.74 0.75 0.75 0.78 0.86 0.88 0.88 0.89 0.88
Increase / (Decrease) in Invested Capital		 -46 -146 -146 -131 -127 -6.63 -4.04 -7.61 -7.65 -35
Enterprise Value (EV)		 888 586 780 813 574 894 809 669 621 837
Market Capitalization		 1,002 692 884 916 689 1,005 922 782 739 958
Book Value per Share		 $29.48 $25.73 $25.61 $26.05 $26.25 $26.96 $26.82 $27.07 $27.04 $27.34
Tangible Book Value per Share		 $14.38 $14.47 $14.22 $14.52 $14.73 $15.35 $15.18 $15.32 $15.23 $15.29
Total Capital		 811 698 683 683 685 695 687 685 680 670
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -114 -107 -105 -103 -115 -111 -113 -113 -118 -121
Capital Expenditures (CapEx)		 7.16 4.39 3.25 2.96 3.04 18 2.57 4.19 1.55 0.83
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 47 35 25 32 27 48 42 44 39 38
Debt-free Net Working Capital (DFNWC)		 132 115 110 119 130 151 152 157 139 142
Net Working Capital (NWC)		 132 115 110 119 130 151 152 157 139 142
Net Nonoperating Expense (NNE)		 0.02 33 -0.68 -0.58 -0.24 -1.09 -0.61 -0.84 -0.94 -0.64
Net Nonoperating Obligations (NNO)		 -114 -107 -105 -103 -115 -111 -113 -113 -118 -121
Total Depreciation and Amortization (D&A)		 9.71 9.44 9.39 9.50 9.33 9.32 9.10 8.97 8.91 8.82
Debt-free, Cash-free Net Working Capital to Revenue		 9.47% 7.14% 5.19% 6.69% 5.50% 9.56% 8.36% 8.59% 7.70% 7.68%
Debt-free Net Working Capital to Revenue		 26.52% 23.54% 22.51% 24.50% 26.27% 29.96% 30.04% 30.76% 27.63% 28.27%
Net Working Capital to Revenue		 26.52% 23.54% 22.51% 24.50% 26.27% 29.96% 30.04% 30.76% 27.63% 28.27%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.14 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02)
Adjusted Weighted Average Basic Shares Outstanding		 27.51M 27.41M 26.58M 26.21M 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M
Adjusted Diluted Earnings per Share		 $0.14 ($4.19) $0.10 ($0.01) $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 27.51M 27.41M 26.61M 26.21M 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.12M 26.68M 26.20M 26.10M 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M
Normalized Net Operating Profit after Tax (NOPAT)		 3.97 -82 1.98 3.93 7.72 5.90 4.66 3.70 6.25 -1.05
Normalized NOPAT Margin		 3.26% -70.92% 1.57% 3.21% 5.90% 4.72% 3.64% 2.95% 4.98% -0.86%
Pre Tax Income Margin		 4.96% -100.95% 4.00% 1.83% 8.21% 7.95% 6.04% 5.86% 7.86% -0.23%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 99.17% -28.67% -47.95% -50.06% -53.07% 255.23% 195.90% 164.94% 212.01% 363.27%

Frequently Asked Questions About Proto Labs' Financials

When does Proto Labs's fiscal year end?

According to the most recent income statement we have on file, Proto Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Proto Labs' net income changed over the last 10 years?

Proto Labs' net income appears to be on a downward trend, with a most recent value of $16.59 million in 2024, falling from $41.64 million in 2014. The previous period was $17.22 million in 2023.

What is Proto Labs's operating income?
Proto Labs's total operating income in 2024 was $19.91 million, based on the following breakdown:
  • Total Gross Profit: $223.20 million
  • Total Operating Expenses: $203.29 million
How has Proto Labs revenue changed over the last 10 years?

Over the last 10 years, Proto Labs' total revenue changed from $209.58 million in 2014 to $500.89 million in 2024, a change of 139.0%.

How much debt does Proto Labs have?

Proto Labs' total liabilities were at $73.36 million at the end of 2024, a 4.8% decrease from 2023, and a 241.3% increase since 2014.

How much cash does Proto Labs have?

In the past 10 years, Proto Labs' cash and equivalents has ranged from $36.71 million in 2017 to $127.60 million in 2020, and is currently $89.07 million as of their latest financial filing in 2024.

How has Proto Labs' book value per share changed over the last 10 years?

Over the last 10 years, Proto Labs' book value per share changed from 10.34 in 2014 to 27.34 in 2024, a change of 164.6%.


Related Companies

This page (NYSE:PRLB) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
Feds Just Admitted It—They Can Take Your Cash
Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...
Priority Gold | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Trump Makes Major Crypto Announcement
Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...
Crypto 101 Media | Sponsored
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
The Exact July Date the AI Correction Will End?
AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...
Brownstone Research | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...
Porter & Company | Sponsored